MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:600-700
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 27
As coordinator: 1
As participant: 26
Sole participant: 0
Coordinator / Participant Ratio: 0.04*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 19.276.286 757.400 4
2020 0 48.187.587 243.750 2
2019 0 100.828.086 0 7
2018 0 38.022.361 505.577 6
2017 3.556.208 23.549.833 1.471.729 1 2
2016 0 21.066.307 750.570 5

Networking:

Partners:

Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV12
NOVARTIS PHARMA10
PFIZER LIMITED10
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG8
KATHOLIEKE UNIVERSITEIT LEUVEN8
BAYER7
SANOFIAVENTIS7
ABBVIE INC6
F HOFFMANNLA ROCHE6
ELI LILLY AND COMPANY LIMITED5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
NOVO NORDISK5
TAKEDA PHARMACEUTICALS INTERNATIONAL5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD5
UCB BIOPHARMA5
UNIVERSITY OF DUNDEE5
ASTELLAS PHARMA EUROPE BV4
ASTRAZENECA4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
INSTITUT DE RECHERCHES SERVIER4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
LEIDS UNIVERSITAIR MEDISCH CENTRUM4
MERCK SHARP & DOHME CORP4
TAKEDA DEVELOPMENT CENTRE EUROPE4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
AMGEN LIMITED3
ASTRAZENECA AB3
BAYER AKTIENGESELLSCHAFT3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
COVANCE LABORATORIES3
GRUNENTHAL3
UNIVERSITEIT UTRECHT3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UNIVERSITY OF OSLO3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FORUM DES PATIENTS EUROPEENS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
H LUNDBECK AS2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
KING'S COLLEGE LONDON2
LUND UNIVERSITY2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
OWKIN FRANCE2
PFABRUSSELS2
SANOFIAVENTIS DEUTSCHLAND2
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT2
SERVICIO MADRILENO DE SALUD2
STATENS LEGEMIDDELVERK2
STICHTING LYGATURE2
STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
SYNCOM BV2
TECHNISCHE UNIVERSITAET DARMSTADT2
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY2
THE EUROPEAN MEDICINES AGENCY2
THE SYNERGIST2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITAET ZUERICH2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DE GENEVE2
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF DURHAM2
UNIVERSITY OF LEEDS2
UPPSALA UNIVERSITET2
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV2
3D LIFEPRINTS UK1
ABBVIE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACCELOPMENT1
ACTA1
ACTELION PHARMACEUTICALS1
ADD ESSENS1
ADELPHI VALUES1
AGENZIA ITALIANA DEL FARMACO1
AGENZIA REGIONALE DI SANITA1
AGROPARISTECH INNOVATION1
AIBIOPHARMA1
AICURIS ANTIINFECTIVE CURES1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ALEXION SERVICES EUROPE SPRL1
ALLERGAN LIMITED1
ALTERNATIVE PLANTS SIA1

Constancy:

Total number of partners: 621
Partner loyalty:
Frequent Partner: (> 2 projects): 179
Rare Partner: 442
Frequent / Rare Partner Ratio: 0.4

Project overview:

Start dateProjectacronymrolefundingpartners
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90330
2021-07-01Real World Handling of Protein Drugs - Exploration, Evaluation and Education RealHOPEparticipant3.139.98425
2021-05-01Innovative high-value cosmetic products from plants and plant cells InnCoCellsparticipant7.905.55918
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2020-10-01HIGH PERFORMING AND SAFE SOLVENT DERIVED FROM CELLULOSIC FEEDSTOCKS ReSoluteparticipant11.628.40116
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Appearance Printing - European Advanced Research School ApPEARSparticipant4.265.88415
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01Chemical Engineering Immersive Learning CHARMINGparticipant4.060.22813
2018-10-01Using the smart matrix approach to enhance TADF-OLED efficiency and lifetime TADFlifeparticipant3.942.03721
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2018-01-01Computational ONcology TRaining Alliance CONTRAparticipant3.863.97815
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19420
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Development of high-performance, hyperfluorescence OLEDs for use in display applications and solid state lighting HyperOLEDcoordinator3.556.2085
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-10-01Continuous Resolution and Deracemization of Chiral Compounds by Crystallization COREparticipant3.920.69015
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26913
2016-05-01Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines PEARRLparticipant3.856.25310
2016-02-01Production technology to achieve low Cost and Highly Efficient phOtovoltaic Perovskite Solar cells CHEOPSparticipant3.299.09512